Stryker Co. (SYK) Holdings Increased by Teachers Advisors LLC
Teachers Advisors LLC grew its holdings in shares of Stryker Co. (NYSE:SYK) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 673,026 shares of the medical technology company’s stock after acquiring an additional 64,447 shares during the quarter. Teachers Advisors LLC’s holdings in Stryker were worth $104,211,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of SYK. Amundi Pioneer Asset Management Inc. acquired a new stake in Stryker during the 4th quarter worth about $49,056,000. Lazard Asset Management LLC grew its holdings in Stryker by 15.5% during the 4th quarter. Lazard Asset Management LLC now owns 2,208,379 shares of the medical technology company’s stock worth $341,945,000 after acquiring an additional 296,550 shares during the period. Ardevora Asset Management LLP acquired a new stake in Stryker during the 3rd quarter worth about $34,568,000. Janus Henderson Group PLC grew its holdings in Stryker by 19.2% during the 3rd quarter. Janus Henderson Group PLC now owns 1,214,733 shares of the medical technology company’s stock worth $172,517,000 after acquiring an additional 195,479 shares during the period. Finally, Deutsche Bank AG grew its holdings in Stryker by 45.2% during the 4th quarter. Deutsche Bank AG now owns 616,781 shares of the medical technology company’s stock worth $95,496,000 after acquiring an additional 191,929 shares during the period. Hedge funds and other institutional investors own 75.71% of the company’s stock.
SYK has been the subject of several research reports. Royal Bank of Canada restated a “buy” rating and issued a $175.00 target price on shares of Stryker in a research note on Tuesday, January 9th. ValuEngine upgraded Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. SunTrust Banks restated a “buy” rating and issued a $161.00 target price on shares of Stryker in a research note on Friday, November 17th. Piper Jaffray Companies restated a “buy” rating and issued a $170.00 target price on shares of Stryker in a research note on Wednesday, January 31st. Finally, Guggenheim restated a “buy” rating on shares of Stryker in a research note on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Stryker presently has an average rating of “Buy” and a consensus target price of $163.85.
Stryker (NYSE:SYK) last posted its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. The company had revenue of $3.47 billion for the quarter, compared to analysts’ expectations of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.56%. Stryker’s revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 EPS. sell-side analysts forecast that Stryker Co. will post 7.12 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be issued a $0.47 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.13%. Stryker’s dividend payout ratio (DPR) is presently 70.15%.
In other news, VP Katherine Ann Owen sold 3,700 shares of the business’s stock in a transaction on Monday, March 5th. The shares were sold at an average price of $161.66, for a total transaction of $598,142.00. Following the completion of the transaction, the vice president now directly owns 7,596 shares in the company, valued at approximately $1,227,969.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Yin C. Becker sold 23,221 shares of the business’s stock in a transaction on Friday, March 9th. The shares were sold at an average price of $165.96, for a total transaction of $3,853,757.16. Following the transaction, the vice president now owns 10,499 shares of the company’s stock, valued at $1,742,414.04. The disclosure for this sale can be found here. Insiders sold a total of 43,611 shares of company stock worth $7,178,719 in the last ninety days. 7.40% of the stock is currently owned by insiders.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.